Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...

Robust project management is essential in any manufacturing business, particularly where strict regulations and complex ...

Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again ...

BETHANY, MISSOURI / ACCESS Newswire / May 1, 2025 / Emergency Care Partners (ECP) and its Missouri-based partner physician group, Missouri Physician Partners (MPP), have announced an expansion to ...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

Aviva’s in-house capital unit that invests in a range of infrastructure and real estate projects, and mixed-use developer ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces that the first patient has been enrolled in the Phase 1 clinical trial of its drug candidate 177Lu ...

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

SIOUX FALLS, SD / ACCESS Newswire / May 1, 2025 / Teen mental health has reached a crisis point in the United States. According to the CDC, nearly 1 in 3 high school girls reported seriously ...

Cash Burn of $4.0 million in Q1 remains in line with projected quarterly rangeCash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the ...

Clinigen, the global specialist pharmaceutical services group, today announced the appointment of Nihad Hasagic as Senior Vice President for Clinigen Lifecycle Services (SVP CLS). Reporting to the ...

Aspira Women's Health Submits the Third Milestone of ARPA-H $10 Million Award  AUSTIN, TX / ACCESS Newswire / May 1, 2025 / Aspira Women's Health Inc. ("Aspira") (OTC PINK:AWHL), a bio-analytical ...